PTC Therapeutics

PTCT | NASDAQ | 0 Obserwujący

$48.52

-0.76%

-$0.37

Obserwuj

Overview Metrics Financials

Fair Price

$77.63

Overvalued by 23.1%

Aby wyświetlić sprawiedliwą cenę akcji, musisz być członkiem Bulios Black.

Profile

PTC Therapeutics, Inc. is an American biotechnology company that specializes in the development and commercialization of drugs for genetic and rare diseases. Founded in 1998, the company focuses on molecular therapies and innovative approaches to treating conditions that lack sufficient treatment options. PTC Therapeutics is dedicated to researching and developing drugs that target the genetic mechanisms of diseases, including conditions like Duchenne muscular dystrophy and other rare genetic disorders. The company has a global reach, with its drugs distributed in various countries.

Feed

There are no posts to show right now.

PTC Therapeutics

Fair Price

Profile

Feed

Zaloguj się do Bulios

Utwórz profil Bulios

Dlaczego Bulios?